Alto Neuroscience rallies over $40m

Alto Neuroscience, a provider of a clinical-stage pipeline of precision psychiatry medicines, has raised over $40 million in funding.

Alto Neuroscience, a provider of a clinical-stage pipeline of precision psychiatry medicines, has raised over $40 million in funding. The investors include Apeiron Investment Grouop.

Source: Press Release